Protalix Biotherapeutics Inc (NYSE American:PLX)

0.6701
Delayed Data
As of Feb 23
 0.0001 / +0.01%
Today’s Change
0.48
Today|||52-Week Range
1.51
+1.35%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 3.55, with a high estimate of 5.00 and a low estimate of 2.10. The median estimate represents a +429.77% increase from the last price of 0.67.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$9.7M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.33%
 
 
 
 
 
 
Growthannually -55.17%
 
 
 
 
 
 

Sales

Growthquarterly 28.89%
 
 
 
 
 
 
Growthannually 201.76%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.